THE LONG-TERM IMPACT OF BEDAQUILINE-CONTAINING REGIMENS ON COST BURDEN OF DRUG-RESISTANT TUBERCULOSIS IN INDIA

被引：0
|
作者：
Agnarson, M. A. [1 ]
Potluri, R. [2 ]
Bhandari, H. [3 ]
Dhir, A. [4 ]
Kumar, A. [3 ]
Gupta, V [5 ]
Raute, L. [5 ]
Shah, N. [5 ]
Kambili, C. [6 ]
Metz, L. [1 ]
机构：
[1] Johnson & Johnson, New Brunswick, NJ USA
[2] SmartAnalyst Inc, New York, NY USA
[3] SmartAnalyst India Pvt Ltd, Gurgaon, India
[4] SmartAnalyst India Pvt Ltd, Gurgaon, HR, India
[5] Janssen India, Mumbai, Maharashtra, India
[6] Johnson & Johnson, South Raritan, NJ USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN48
引用
收藏
页码：S648 / S648
页数：1
相关论文
共 50 条
  • [1] Long-term impact of the adoption of bedaquiline-containing regimens on the burden of drug-resistant tuberculosis in China
    Abela Mpobela Agnarson
    Xiao Chun Wang
    Ravi Potluri
    Hitesh Bhandari
    Amit Dhir
    Chrispin Kambili
    Laurent Metz
    [J]. BMC Infectious Diseases, 20
  • [2] Long-term impact of the adoption of bedaquiline-containing regimens on the burden of drug-resistant tuberculosis in China
    Agnarson, Abela Mpobela
    Wang, Xiao Chun
    Potluri, Ravi
    Bhandari, Hitesh
    Dhir, Amit
    Kambili, Chrispin
    Metz, Laurent
    [J]. BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [3] ASSESSMENT OF LONG-TERM IMPACT OF BEDAQUILINE-CONTAINING REGIMENS ON BURDEN OF DRUG-RESISTANT TUBERCULOSIS IN INDIA, A STATE TRANSITION MODEL ANALYSIS
    Agnarson, Abela Mpobela
    Gupta, Vandita
    Raute, Lalit
    Potluri, Ravi
    Bhandari, Hitesh
    Dhir, Amit
    Kumar, Amit
    Kambili, Chrispin
    Metz, Laurent
    Mattson, Gunnar
    [J]. MEDICAL DECISION MAKING, 2020, 40 (01) : E1 - E2
  • [4] THE LONG-TERM IMPACT OF BEDAQUILINE-CONTAINING REGIMENS ON COST BURDEN TO THE HEALTHCARE SYSTEM AND FAMILIES OF PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS IN INDONESIA
    Agnarson, Mpobela A.
    Chiou, C. F.
    Mansjur, H.
    Insani, U. C.
    Potluri, R.
    Dhir, A.
    Kambili, C.
    Metz, L.
    [J]. VALUE IN HEALTH, 2020, 23 : S352 - S352
  • [5] Long-term results of treatment with bedaquiline in patients with drug-resistant tuberculosis
    Morozova, Tatyana
    Otpuschenniykova, Olga
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [6] Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery
    Borisov, Sergey E.
    D'Ambrosio, Lia
    Centis, Rosella
    Tiberi, Simon
    Dheda, Keertan
    Alffenaar, Jan-Willem
    Amale, Rohit
    Belilowski, Evgeny
    Bruchfeld, Judith
    Canneto, Barbara
    Denholm, Justin
    Duarte, Raquel
    Esmail, Aliasgar
    Filippov, Alex
    Forsman, Lina Davies
    Gaga, Mina
    Ganatra, Shashank
    Igorevna, Gaida Anastasia
    Mastrapa, Barbara Lazaro
    Manfrin, Vinicio
    Manga, Selene
    Maryandyshev, Andrey
    Massard, Gilbert
    Gonzalez Montaner, Pablo
    Mullerpattan, Jai
    Juan Palmero, Domingo
    Pontarelli, Agostina
    Papavasileiou, Apostolos
    Pontali, Emanuele
    Leyet, Rodolfo Romero
    Spanevello, Antonio
    Udwadia, Zarir Farokh
    Viggiani, Pietro
    Visca, Dina
    Sotgiu, Giovanni
    Migliori, Giovanni Battista
    [J]. JOURNAL OF INFECTION, 2019, 78 (01) : 35 - 39
  • [7] Bedaquiline- versus injectable-containing drug-resistant tuberculosis regimens: a cost-effectiveness analysis
    Ionescu, Ana-Maria
    Agnarson, Abela Mpobela
    Kambili, Chrispin
    Metz, Laurent
    Kfoury, Jonathan
    Wang, Steven
    Williams, Abeda
    Singh, Vikram
    Thomas, Adrian
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2018, 18 (06) : 677 - 689
  • [8] Long-term plasma pharmacokinetics of bedaquiline for multidrug- and extensively drug-resistant tuberculosis
    Perrineau, S.
    Lachatre, M.
    Le, M. P.
    Rioux, C.
    Loubet, P.
    Frechet-Jachym, M.
    Gonzales, M. Cervantes
    Grall, N.
    Bouvet, E.
    Veziris, N.
    Yazdanpanah, Y.
    Peytavin, G.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2019, 23 (01) : 99 - 104
  • [9] Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis
    Conradie, Francesca
    Bagdasaryan, Tatevik R. R.
    Borisov, Sergey
    Howell, Pauline
    Mikiashvili, Lali
    Ngubane, Nosipho
    Samoilova, Anastasia
    Skornykova, Sergey
    Tudor, Elena
    Variava, Ebrahim
    Yablonskiy, Petr
    Everitt, Daniel
    Wills, Genevieve H. H.
    Sun, Eugene
    Olugbosi, Morounfolu
    Egizi, Erica
    Li, Mengchun
    Holsta, Alda
    Timm, Juliano
    Bateson, Anna
    Crook, Angela M. M.
    Fabiane, Stella M. M.
    Hunt, Robert
    McHugh, Timothy D. D.
    Tweed, Conor D. D.
    Foraida, Salah
    Mendel, Carl M. M.
    Spigelman, Melvin
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (09): : 810 - 823
  • [10] Outcomes of bedaquiline-containing regimen in the treatment of adults with drug-resistant tuberculosis in a tertiary care center in Rajasthan
    Prince, Roshni Mary
    Khangarot, Suman
    Haque, Qazi Faizanul
    Mittal, Anish
    Somani, Ramdhan
    Grover, Mansha
    Prince, Roshni Mary
    [J]. MONALDI ARCHIVES FOR CHEST DISEASE, 2024, 94 (02)
12345